SG Americas Securities LLC Acquires New Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

SG Americas Securities LLC acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 5,049 shares of the company’s stock, valued at approximately $364,000.

Several other hedge funds also recently made changes to their positions in the company. State Board of Administration of Florida Retirement System raised its holdings in Prestige Consumer Healthcare by 77.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares in the last quarter. BNP Paribas Financial Markets raised its stake in shares of Prestige Consumer Healthcare by 143.4% during the 1st quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company’s stock worth $3,718,000 after buying an additional 30,191 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $550,000. CANADA LIFE ASSURANCE Co boosted its stake in shares of Prestige Consumer Healthcare by 19.4% in the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock valued at $3,453,000 after buying an additional 7,715 shares in the last quarter. Finally, Atria Investments Inc acquired a new position in Prestige Consumer Healthcare during the first quarter worth $1,246,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.3 %

Prestige Consumer Healthcare stock opened at $72.55 on Friday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $75.80. The firm has a market capitalization of $3.60 billion, a price-to-earnings ratio of 17.74, a price-to-earnings-growth ratio of 1.98 and a beta of 0.47. The stock’s fifty day moving average is $71.34 and its two-hundred day moving average is $69.29. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The firm’s revenue was down 4.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.06 EPS. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.